The pharmaceutical industry in 2025 has undergone a massive transformation, with virtual clinical trials becoming a standard part of the drug development lifecycle. By simulating how a new compound interacts with thousands of virtual patients, researchers can identify potential side effects and efficacy concerns much earlier in the process. The Healthcare Digital Twin Arena enables "in silico"...